LOUISVILLE, Ky. / Feb 07, 2024 / Business Wire / Humana Inc. (NYSE: HUM), a leading U.S. health insurer and healthcare services company, continues to make strides in advancing health equity by releasing the findings of its new pilot study published in the American Journal of Managed Care. Humana’s screenings analysis marks the first study conducted by a national health plan, focusing on the often overlooked but critical aspects of structural determinants of health, like perceived discrimination and health literacy.
“Learnings from this pilot have been very informative for our business and have led to a number of programs and interventions across the [Humana] enterprise,” said J. Nwando Olayiwola, MD, MPH, Chief Health Equity Officer & SVP at Humana. “We have expanded screening to digital and live modalities, strengthened our staff capabilities around understanding and responding to low/limited health literacy, and improved engagement with our members. This is the goal of any thoughtful screening programs- leveraging insights for tangible action.”
While many health plans screen for social determinants of health— conditions in which people live, work, play, learn, and worship— few systematically screen patients for structural determinants of health, which are the economic and social experiences and policies that influence health, such as discrimination and health literacy.
Humana has taken a decisive step forward by analytically screening patients for structural determinants of health, which significantly influence one's overall health and well-being. With this pilot screening, Humana aims to gain a deeper understanding of its members' experiences, allowing for the development of targeted interventions that effectively address these barriers.
The recently conducted pilot by Humana focused on the feasibility of screening newly enrolled Medicare Advantage members for health literacy and perceived healthcare discrimination via a carefully administered telephonic survey. The results revealed varying levels of feasibility for health literacy and perceived healthcare discrimination screenings, with health literacy yielding a higher response rate. Other key findings from the pilot study include:
Candy Magaña, MPA, Director of Health Equity Innovation, Solutions, and Transformation at Humana, emphasizes the importance of this study, stating, “Because the literature on implementing these screenings in managed care settings is so limited, we felt it was important to understand the feasibility of screening using evidence-based, validated screening instruments and train our staff to administer them. This builds off our longstanding expertise in screening members for various social needs.”
About Humana
Humana Inc. is committed to putting health first – for our teammates, customers, and company. Through our Humana insurance services and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.
Last Trade: | US$357.86 |
Daily Change: | -7.28 -1.99 |
Daily Volume: | 920,436 |
Market Cap: | US$43.090B |
August 19, 2024 August 08, 2024 July 31, 2024 July 25, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB